We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 06, 2020

Shallow Whole-Genome Sequencing From Plasma Identifies FGFR1-Amplified Breast Cancers and Predicts OS



Additional Info

Shallow Whole-Genome Sequencing From Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival
Cancers (Basel) 2020 Jun 06;[EPub Ahead of Print], C Bourrier, JY Pierga, L Xuereb, H Salaun, C Proudhon, MR Speicher, J Belic, E Heitzer, BP Lockhart, N Guigal-Stephan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading